Resources Repository
-
ToolWeb Portal 2023CDC Resource Portal: Diagnostic Tests for SARS-CoV-2
The Centers for Disease Control and Prevention (CDC) provides a broad range of resources about …
The Centers for Disease Control and Prevention (CDC) provides a broad range of resources about diagnostic tests for SARS-CoV-2 aimed at the general public, health professionals and laboratory personnel. The overviews and guidelines for health professionals provide comprehensive information about the current available diagnostics, their strengths and limitations, their performance characteristics and guidelines for their use and interpretation. Selected topics included are provided below. Overview of Testing for SARS-CoV-2, the Virus That Causes COVID-19. Interim…
Infectious Diseases | Test Performance | Clinical Care | Health/Medicine | Science/Technology | North America -
ReportPublication 2022Investment Case for New Tuberculosis Vaccines
Investing more financial resources to accelerate scientific progress toward an effective tuberculosis (TB) vaccine will …
Investing more financial resources to accelerate scientific progress toward an effective tuberculosis (TB) vaccine will save lives, fight antimicrobial resistance, advance health equity, improve economic growth, and bring a substantial return on investment. This World Health Organization (WHO) report describes the full value proposition for new TB vaccines. These analyses articulate the broader economic impacts of new TB vaccines to guide global stakeholders when making investment decisions for novel TB vaccines and to plan for…
Infectious Diseases | Cost-Effectiveness Analysis | Economics/Finance | Health/Medicine | Global -
ReportPublication 2021Valuing COVID-19 Mortality and Morbidity Risks
In this report, the researchers develop an approach for valuing COVID-19 mortality and morbidity risk …
In this report, the researchers develop an approach for valuing COVID-19 mortality and morbidity risk reductions that builds on the U.S. Department of Health and Human Services (HHS) Guidelines for Regulatory Impact Analysis. They review the differences between COVID-19 mortality risks and the types of risks that are more commonly studied, and find that the impacts of these differences on the value of mortality risk reductions (the value per statistical life, VSL) are uncertain. They…
Infectious Diseases | Preferences/Values | Benefit-Cost Analysis | Policy/Regulation | Government/Law | North America -
ReportPublication 2021What the American Public Thinks About Vaccines and How Framing Can Help
This paper explores the question of public understandings, beliefs, and attitudes about vaccination in general, …
This paper explores the question of public understandings, beliefs, and attitudes about vaccination in general, and childhood vaccination more specifically. The authors provide an overview of the existing literature on public thinking about vaccination and on effective communication strategies and interventions that have been either suggested or empirically tested. This description was extracted from the publication abstract.
Infectious Diseases | Preferences/Values | Child/Nutrition | Social Determinants | Culture/Society | Health/Medicine | Science/Technology | North America -
NewsPublication 2021Dispelling Misinformation, Countering Vaccine Hesitancy Vital to Beat COVID-19, Countries Affirm
This article discusses a political declaration launched by the United Nations General Assembly and addresses …
This article discusses a political declaration launched by the United Nations General Assembly and addresses misinformation and countering vaccine hesitancy as countries pledge to “work together as one” to defeat the COVID-19 pandemic, and help people and the planet to recover better. This description was adapted from the article summary.
Infectious Diseases | Social Determinants | Global Governance | Culture/Society | Health/Medicine | Science/Technology | Global -
NewsPublication 2020Online Anti-Vaccine Movement in the Age of COVID-19
This article discusses a recent report by the Centre for Countering Digital Hate (CCDH) that …
This article discusses a recent report by the Centre for Countering Digital Hate (CCDH) that lambasted social media companies for allowing the anti-vaccine movement to remain on their platforms. The CCDH report noted that social media accounts held by so-called anti-vaxxers have increased their following by at least 7-8 million people since 2019. “The decision to continue hosting known misinformation content and actors left online anti-vaxxers ready to pounce on the opportunity presented by coronavirus,”…
Infectious Diseases | Preferences/Values | Social Determinants | Culture/Society | Health/Medicine | Science/Technology | North America -
NewsPublication 2020Managing the COVID-19 Infodemic: Promoting Healthy Behaviors and Mitigating the Harm from Misinformation and Disinformation
The COVID-19 pandemic is the first in history in which technology and social media are …
The COVID-19 pandemic is the first in history in which technology and social media are being used on a massive scale to keep people safe, informed, productive, and connected. At the same time, the technology we rely on to keep connected and informed enables and amplifies an infodemic that continues to undermine the global response and jeopardizes measures to control the pandemic. This description was adapted from the joint statement.
Infectious Diseases | Decision Psychology | Preferences/Values | Social Determinants | Health Systems | Global Governance | Culture/Society | Government/Law | Health/Medicine | Science/Technology | Global -
ToolWeb Portal 2023General Audience Toolkit
This toolkit contains resources for anyone who wants to help increase public confidence in and …
This toolkit contains resources for anyone who wants to help increase public confidence in and uptake of COVID-19 vaccines. This toolkit includes information from the Centers for Disease Control and Prevention (CDC) and culturally tailored materials from the U.S. Department of Health and Human Services (HHS) COVID-19 public education campaign and its team of multicultural experts. This description was extracted from the toolkit website.
Infectious Diseases | Preferences/Values | Social Determinants | Culture/Society | Health/Medicine | Science/Technology | North America -
ToolInteractive 2020COVID-19 Antibody Tests: Calculator for Interpreting Test Results
Antibody testing can determine previous exposure to SARS-CoV-2 virus. This interactive calculator, linked to the article …
Antibody testing can determine previous exposure to SARS-CoV-2 virus. This interactive calculator, linked to the article below* on antibody testing for SARS-CoV-2 virus, allows users to vary the prior probability of infection, the sensitivity of SARS-CoV-2 antibody testing, and the specificity of SARS-CoV-2 antibody testing. Key points made in the article accompanying the interactive include: (1) antibody testing is likely to be most useful 2 weeks after infection, (2) sensitivity and specificity will vary over time and…
Infectious Diseases | Probability/Bayes | Test Performance | Technology Assessment | Clinical Care | Health/Medicine | Science/Technology